Evolution of acute myelogenous leukemia stem cell properties after treatment and progression

Most cancers evolve over time as patients initially responsive to therapy acquire resistance to the same drugs at relapse. Cancer stem cells have been postulated to represent a therapy-refractory reservoir for relapse, but formal proof of this model is lacking. We prospectively characterized leukemi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Blood
Main Authors: Ho, Tzu-Chieh, LaMere, Mark, Stevens, Brett M., Ashton, John M., Myers, Jason R., O’Dwyer, Kristen M., Liesveld, Jane L., Mendler, Jason H., Guzman, Monica, Morrissette, Jennifer D., Zhao, Jianhua, Wang, Eunice S., Wetzler, Meir, Jordan, Craig T., Becker, Michael W.
格式: Artigo
語言:Inglês
出版: American Society of Hematology 2016
主題:
Plenary Paper
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5043124/
https://ncbi.nlm.nih.gov/pubmed/27421961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-02-695312
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍